Gastrointestinal endoscopy can be safely performed during pandemic SARS-CoV-2 infection in Central Italy.
Journal
European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874
Informations de publication
Date de publication:
01 12 2021
01 12 2021
Historique:
pubmed:
3
4
2021
medline:
27
1
2022
entrez:
2
4
2021
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly contagious; gastrointestinal endoscopies are considered risky procedures for the endoscopy staff. Data on the SARS-CoV-2-exposure/infection rate of gastrointestinal endoscopy staff is scarce. This study aimed to assess the SARS-CoV-2-exposure/infection rate among gastrointestinal endoscopists/nurses performing gastrointestinal endoscopies before and after the adoption of specific prevention measures. Cross-sectional study in a teaching hospital (Rome, Central Italy) on retrospective data (9 March-15 April 2020) of consecutive gastrointestinal endoscopies, characteristics of procedures, patients and endoscopy staff, SARS-CoV-2-exposure/positivity of patients and staff before and after adoption of prevention measures. Exposed staff tested for SARS-CoV-2 by nasopharyngeal swabs(RNA-PCR) and serology. A total of 130 gastrointestinal endoscopies were performed in 130 patients (age 66 ± 14 years, 51% women, 51% inpatients, 56.9% lower). A total of 12 (9.2%) patients were SARS-CoV-2-positive and 14(10.8%) had a high risk of potential infection. Of the endoscopy staff (n = 16, 5 endoscopists, 8 nurses and 3 residents), 14 (87.5%) were exposed to SARS-CoV-2-infected and 16 (100%) to potentially infected patients. 3/5 and 5/5 endoscopists were exposed to actual and potential, 1/3 and 3/3 residents to actual and potential and 8/8 nurses to actual and potential infection, respectively. None of the staff was found to be infected with SARS-CoV-2. None experienced fever or any other suspicious symptoms of coronavirus disease 2019. Before the adoption of prevention measures, more endoscopists/nurses were in the endoscopy room than after (3.5 ± 0.6 vs. 2.1 ± 0.3, P < 0.0001). Despite supposed high infection risk, gastrointestinal endoscopies may be safe for the endoscopy staff during the SARS-CoV-2 pandemic.
Identifiants
pubmed: 33795580
doi: 10.1097/MEG.0000000000002155
pii: 00042737-202112001-00068
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e505-e512Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
World Health Organization. Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020.https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020. Accessed 24 April 2020.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al.; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382:1708–1720.
Zhou Z, Zhao N, Shu Y, Han S, Chen B, Shu X. Effect of gastrointestinal symptoms on patients infected with COVID-19. Gastroenterology 2020; 158:2294–2297.
Jin X, Lian J-S, Hu J-H, Gao J, Zheng L, Zhang Y-M, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020; 69:1002–1009.
Zhang JJ, Dong X, Cao YY, Yuan Y-D, Yang Y-B, Yan Y-Q, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 5:1730–1741.
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol 2020; 115:766–773.
Nobel YR, Phipps M, Zucker J, Lebwohl B, Wang TC, Sobieszczyk ME, Freedberg DE. Gastrointestinal symptoms and COVID-19: case-control study from the United States. Gastroenterology 2020; 159:373–375.e2.
Henry BM, de Oliveira MHS, Benoit J, Lippi G. Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis. Intern Emerg Med 2020; 15:857–859.
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020; 395:470–473.
Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 2020; 158:1518–1519.
Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020; 51:843–851.
Repici A, Maselli R, Colombo M, Gabbiadini R, Spadaccini M, Anderloni A, et al. Coronavirus (COVID-19) outbreak: what the department of endoscopy during the COVID-19 pandemic. Gastrointest Endosco 2020; 92:192–197.
Soetikno R, Teoh AYB, Kaltenbach T, Lau JYW, Asokkumar R, Cabral-Prodigalidad P, Shergill A. Considerations in performing endoscopy during the COVID-19 pandemic. Gastrointest Endosc 2020; 92:176–183.
COVID-19: protecting health-care workers. Lancet 2020; 395:922.
ANSA.it. Salute&Benessere.https://www.ansa.it/canale_saluteebenessere/notizie/sanita/2020/03/24/coronavirus-51-medici-positivi-alcuni-allo-spallanzani-_d45d793b-f85d-40b1-bf33-9da8df0243f0.html. [Accessed 22 April 2020].
Ministero della salute. Situazione Covid-19 in Italia. http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioContenutiNuovoCoronavirus.jsp?area=nuovoCoronavirus&id=5351&lingua=italiano&menu=vuoto. [Accessed 22 April 2020].
Repici A, Pace F, Gabbiadini R, Colombo M, Hassan C, Dinelli M, et al.; on behalf of the ITALIAN GI-COVID 19 Working Group. Endoscopy units and the COVID-19 outbreak: a multi-center experience from Italy. Gastroenterology 2020; 159:363–366.e3.
Danese S, Ran ZH, Repici A, Tong J, Omodei P, Aghemo A, Malesci A. Gastroenterology department operational reorganisation at the time of Covid-19 outbreak: an Italian and Chinese experience. Gut 2020; 69:981–983.
Castro Filho EC, Castro R, Fernandes FF, Pereira G, Perazzo H. Gastrointestinal endoscopy during the COVID-19 pandemic: an updated review of guidelines and statements from international and national societies. Gastrointest Endosc 2020; 92:440–445.e6.
Gralnek IM, Hassan C, Beilenhoff U, Antonelli G, Ebigbo A, Pellisè M, et al. ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy 2020; 52:483–490.
Repici A, Aragona G, Cengia G, Cantù P, Spadaccini M, Maselli R, et al. Low risk of Covid-19 transmission in GI endoscopy. Gut 2020; 69:1925–1927.
fismad. COVID-19: Consigli FISMAD per l’assistenza ai pazienti con malattie dell’apparato digerente e per gli operatori sanitari in Gastroenterologia.https://fismad.it/wp-content/uploads/2020/03/COVID-19_FISMAD.pdf. [Accessed 24 April 2020].
Calderwood AH, Chapman FJ, Cohen J, Cohen LB, Collins J, Day LW, et al.; ASGE Ensuring Safety in the Gastrointestinal Endoscopy Unit Task Force. Guidelines for safety in the gastrointestinal endoscopy unit. Gastrointest Endosc 2014; 79:363–372.
Calderwood AH, Day LW, Muthusamy VR, Collins J, Hambrick RD III, et al.; ASGE Quality Assurance in Endoscopy Committee. ASGE guideline for infection control during GI endoscopy. Gastrointest Endosc 2018; 87:1167–1179.
Beilenhoff U, Biering H, Blum R, Brljak J, Cimbro M, Dumonceau JM, et al. Reprocessing of flexible endoscopes and endoscopic accessories used in gastrointestinal endoscopy: Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA) - update 2018. Endoscopy 2018; 50:1205–1234.
Perisetti A, Gajendran M, Boregowda U, Bansal P, Goyal H. COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies. Dig Endosc 2020; 32:715–722.
Ferreira-Silva J, Peixoto A, Rodrigues-Pinto E, Macedo G. Implications of COVID-19 for the busy gastroenterologist. Eur J Gastroenterol Hepatol 2021; 33:319–324.
Nussbaumer-Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, et al. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst Rev 2020; 4:CD013574.